SCHEMBL1368544

SCHEMBL1368544

c1cnc2c(c1)ccc1nccn12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
PDE2A O00408 1/20 0.41
PDE6D O43924 1/20 0.41
PDE8A O60658 1/20 0.41
PDE5A O76074 1/20 0.41
PDE9A O76083 1/20 0.41
PDE8B O95263 1/20 0.41
PDE6A P16499 1/20 0.41
PDE6G P18545 1/20 0.41
PDE4A P27815 1/20 0.41
PDE6B P35913 1/20 0.41
PDE6C P51160 1/20 0.41
PDE1A P54750 1/20 0.41
PDE1B Q01064 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE7A Q13946 1/20 0.41
PDE6H Q13956 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31624542 1.00 PARP1 (0.42) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL1368573 0.78 HRH4 (0.40) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL1104796 0.74 ROCK1 (0.46) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL11536510 0.74 ROCK1 (0.46) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL20567950 0.74 MKNK2 (0.44) CDK8ROCK1CHEK1MAP4K4CSF1R
SCHEMBL1370460 0.73 PARP1 (0.42) PARP1PDE2APDE6DPDE8APDE5A
SCHEMBL9611712 0.73 ALDH1A1 (0.40) PARP1DYRK1AKDM4EGMNNLMNA
SCHEMBL30556196 0.69 ALDH1A1 (0.46) PARP1KDM4EGMNNLMNATP53
SCHEMBL30975746 0.69 CDK8 (0.38) PDE2APDE6DPDE8APDE5APDE9A
SCHEMBL16244139 0.69 RPS6KA5 (0.47) PDE10ACDK8ROCK1CHEK1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169282-B2 Metal complexes MERCK PATENT GMBH (DE) 2015-10-27 US disclosed
US-9169282-B2 Metal complexes MERCK PATENT GMBH (DE) 2015-10-27 US disclosed
US-9169282-B2 Metal complexes MERCK PATENT GMBH (DE) 2015-10-27 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
WO-2010086089-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110284799-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 PARP1 1422/4885PDE2A 4816/4885PDE6D 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.